Filing Details
- Accession Number:
- 0001261380-13-000037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-13 16:45:04
- Reporting Period:
- 2013-06-11
- Filing Date:
- 2013-06-13
- Accepted Time:
- 2013-06-13 16:45:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1006045 | Iridex Corp | IRIX | Electromedical & Electrotherapeutic Apparatus (3845) | 770210467 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1422484 | H James Mackaness | 1212 Terra Bella Avenue Mountain View CA 94043 | Cfo And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-06-11 | 300 | $0.90 | 22,200 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-06-11 | 300 | $5.61 | 21,900 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-06-11 | 900 | $2.49 | 45,830 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-06-11 | 900 | $5.61 | 44,930 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option Right to Buy | Disposition | 2013-06-11 | 300 | $0.00 | 300 | $0.90 |
Common Stock | Stock Option Right to Buy | Disposition | 2013-06-11 | 900 | $0.00 | 900 | $2.49 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
21,900 | 2009-01-11 | 2015-12-11 | No | 4 | M | Direct |
44,930 | 2009-02-02 | 2015-01-02 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was pursuant to the Reporting Person's Rule 10b5-1 Selling Plan that was effective March 7, 2013.
- This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3.
- The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest each month.
- This option was granted pursuant to IRIDEX Corporation's incentive 1998 Stock Plan and is exempt pursuant to Rule 16b-3.